vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and SANFILIPPO JOHN B & SON INC (JBSS). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $314.8M, roughly 1.1× SANFILIPPO JOHN B & SON INC). SANFILIPPO JOHN B & SON INC runs the higher net margin — 5.7% vs -0.8%, a 6.5% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 4.6%). SANFILIPPO JOHN B & SON INC produced more free cash flow last quarter ($40.0M vs $36.1M). Over the past eight quarters, SANFILIPPO JOHN B & SON INC's revenue compounded faster (7.6% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
John B. Sanfilippo & Son Inc. (JBSS) is a leading US processor, marketer and distributor of high-quality tree nuts, peanuts, dried fruits, and value-added snack products. It serves retail, foodservice, and industrial ingredient customers primarily across North America, offering both branded and private label product lines.
ASIX vs JBSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $314.8M |
| Net Profit | $-2.8M | $18.0M |
| Gross Margin | 7.6% | 18.8% |
| Operating Margin | -0.7% | 8.3% |
| Net Margin | -0.8% | 5.7% |
| Revenue YoY | 9.4% | 4.6% |
| Net Profit YoY | -892.9% | 32.1% |
| EPS (diluted) | $-0.11 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $314.8M | ||
| Q3 25 | $374.5M | $298.7M | ||
| Q2 25 | $410.0M | $269.1M | ||
| Q1 25 | $377.8M | $260.9M | ||
| Q4 24 | $329.1M | $301.1M | ||
| Q3 24 | $398.2M | $276.2M | ||
| Q2 24 | $453.5M | $269.6M | ||
| Q1 24 | $336.8M | $271.9M |
| Q4 25 | $-2.8M | $18.0M | ||
| Q3 25 | $-2.6M | $18.7M | ||
| Q2 25 | $31.4M | $13.5M | ||
| Q1 25 | $23.3M | $20.2M | ||
| Q4 24 | $352.0K | $13.6M | ||
| Q3 24 | $22.3M | $11.7M | ||
| Q2 24 | $38.9M | $10.0M | ||
| Q1 24 | $-17.4M | $13.5M |
| Q4 25 | 7.6% | 18.8% | ||
| Q3 25 | 6.8% | 18.1% | ||
| Q2 25 | 14.3% | 18.1% | ||
| Q1 25 | 14.2% | 21.4% | ||
| Q4 24 | 3.4% | 17.4% | ||
| Q3 24 | 14.4% | 16.9% | ||
| Q2 24 | 17.9% | 18.5% | ||
| Q1 24 | 0.9% | 18.1% |
| Q4 25 | -0.7% | 8.3% | ||
| Q3 25 | -0.9% | 9.0% | ||
| Q2 25 | 7.7% | 7.5% | ||
| Q1 25 | 7.7% | 10.8% | ||
| Q4 24 | -3.9% | 6.4% | ||
| Q3 24 | 7.5% | 6.2% | ||
| Q2 24 | 11.5% | 5.4% | ||
| Q1 24 | -7.0% | 6.7% |
| Q4 25 | -0.8% | 5.7% | ||
| Q3 25 | -0.7% | 6.3% | ||
| Q2 25 | 7.7% | 5.0% | ||
| Q1 25 | 6.2% | 7.7% | ||
| Q4 24 | 0.1% | 4.5% | ||
| Q3 24 | 5.6% | 4.2% | ||
| Q2 24 | 8.6% | 3.7% | ||
| Q1 24 | -5.2% | 5.0% |
| Q4 25 | $-0.11 | $1.53 | ||
| Q3 25 | $-0.10 | $1.59 | ||
| Q2 25 | $1.15 | $1.15 | ||
| Q1 25 | $0.86 | $1.72 | ||
| Q4 24 | $0.02 | $1.16 | ||
| Q3 24 | $0.82 | $1.00 | ||
| Q2 24 | $1.43 | $0.85 | ||
| Q1 24 | $-0.65 | $1.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $2.4M |
| Total DebtLower is stronger | — | $28.8M |
| Stockholders' EquityBook value | $815.2M | $370.1M |
| Total Assets | $1.7B | $617.7M |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $2.4M | ||
| Q3 25 | $23.7M | $714.0K | ||
| Q2 25 | $18.4M | $585.0K | ||
| Q1 25 | $8.3M | $1.3M | ||
| Q4 24 | $19.6M | $336.0K | ||
| Q3 24 | $17.3M | $442.0K | ||
| Q2 24 | $12.1M | $484.0K | ||
| Q1 24 | $20.6M | $377.0K |
| Q4 25 | — | $28.8M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $14.6M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $6.0M | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | $815.2M | $370.1M | ||
| Q3 25 | $818.2M | $362.8M | ||
| Q2 25 | $823.7M | $360.7M | ||
| Q1 25 | $794.4M | $346.6M | ||
| Q4 24 | $774.6M | $325.6M | ||
| Q3 24 | $766.4M | $310.8M | ||
| Q2 24 | $746.6M | $322.6M | ||
| Q1 24 | $713.2M | $321.8M |
| Q4 25 | $1.7B | $617.7M | ||
| Q3 25 | $1.7B | $598.7M | ||
| Q2 25 | $1.6B | $597.6M | ||
| Q1 25 | $1.6B | $590.0M | ||
| Q4 24 | $1.6B | $545.3M | ||
| Q3 24 | $1.5B | $519.4M | ||
| Q2 24 | $1.5B | $515.6M | ||
| Q1 24 | $1.5B | $491.9M |
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $62.5M |
| Free Cash FlowOCF − Capex | $36.1M | $40.0M |
| FCF MarginFCF / Revenue | 10.0% | 12.7% |
| Capex IntensityCapex / Revenue | 7.7% | 7.1% |
| Cash ConversionOCF / Net Profit | — | 3.48× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $32.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $62.5M | ||
| Q3 25 | $26.6M | $32.1M | ||
| Q2 25 | $21.1M | $36.5M | ||
| Q1 25 | $11.4M | $-25.9M | ||
| Q4 24 | $64.2M | $11.0M | ||
| Q3 24 | $57.3M | $8.9M | ||
| Q2 24 | $50.2M | $35.2M | ||
| Q1 24 | $-36.2M | $5.3M |
| Q4 25 | $36.1M | $40.0M | ||
| Q3 25 | $66.0K | $7.3M | ||
| Q2 25 | $-7.2M | $23.0M | ||
| Q1 25 | $-22.6M | $-37.6M | ||
| Q4 24 | $29.8M | $-2.7M | ||
| Q3 24 | $26.8M | $-3.0M | ||
| Q2 24 | $16.7M | $24.4M | ||
| Q1 24 | $-71.6M | $-1.3M |
| Q4 25 | 10.0% | 12.7% | ||
| Q3 25 | 0.0% | 2.4% | ||
| Q2 25 | -1.7% | 8.6% | ||
| Q1 25 | -6.0% | -14.4% | ||
| Q4 24 | 9.1% | -0.9% | ||
| Q3 24 | 6.7% | -1.1% | ||
| Q2 24 | 3.7% | 9.0% | ||
| Q1 24 | -21.3% | -0.5% |
| Q4 25 | 7.7% | 7.1% | ||
| Q3 25 | 7.1% | 8.3% | ||
| Q2 25 | 6.9% | 5.0% | ||
| Q1 25 | 9.0% | 4.5% | ||
| Q4 24 | 10.4% | 4.5% | ||
| Q3 24 | 7.7% | 4.3% | ||
| Q2 24 | 7.4% | 4.0% | ||
| Q1 24 | 10.5% | 2.4% |
| Q4 25 | — | 3.48× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | 0.67× | 2.70× | ||
| Q1 25 | 0.49× | -1.29× | ||
| Q4 24 | 182.29× | 0.81× | ||
| Q3 24 | 2.57× | 0.77× | ||
| Q2 24 | 1.29× | 3.52× | ||
| Q1 24 | — | 0.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
JBSS
| Sales Channel Directly To Consumer | $263.2M | 84% |
| Sales Channel Commercial Ingredients | $28.0M | 9% |
| Sales Channel Contract Packaging | $23.6M | 8% |
